Preclinical efficacy and safety of a novel lentiviral vector for ex vivo gene therapy of p47phox-deficient chronic granulomatous disease. // Molecular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S1525001626009342?dgcid=rss_sd_all
Preclinical efficacy and safety of a novel lentiviral vector for ex vivo gene therapy of p47phox-deficient chronic granulomatous disease. Molecular Therapy. https://www.sciencedirect.com/science/article/pii/S1525001626009342?dgcid=rss_sd_all
“Preclinical efficacy and safety of a novel lentiviral vector for ex vivo gene therapy of p47phox-deficient chronic granulomatous disease.” Molecular Therapy.
@article{article59244,
title = {Preclinical efficacy and safety of a novel lentiviral vector for ex vivo gene therapy of p47phox-deficient chronic granulomatous disease.},
journal = {Molecular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S1525001626009342?dgcid=rss_sd_all}
}